Megan Chipman, ARNP

NPI: 1821546409
Total Payments
$1,153
2024 Payments
$154.58
Companies
10
Transactions
12

Payment Breakdown by Category

Food & Beverage$1,153 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,153 12 100.0%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $306.61 3 $0 (2024)
GENZYME CORPORATION $122.32 1 $0 (2022)
IDORSIA PHARMACEUTICALS US INC $118.81 1 $0 (2023)
Paratek Pharmaceuticals, Inc. $116.43 1 $0 (2023)
Genentech USA, Inc. $113.71 1 $0 (2021)
Horizon Therapeutics plc $101.20 1 $0 (2022)
ABBVIE INC. $88.53 1 $0 (2022)
ATRICURE, INC. $79.00 1 $0 (2023)
KCI USA, Inc. $58.78 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $47.30 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $154.58 2 Biogen, Inc. ($107.28)
2023 $426.07 4 IDORSIA PHARMACEUTICALS US INC ($118.81)
2022 $399.55 4 GENZYME CORPORATION ($122.32)
2021 $172.49 2 Genentech USA, Inc. ($113.71)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/05/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $47.30 General
Category: Cardiovascular and Metabolism
04/19/2024 Biogen, Inc. Food and Beverage In-kind items and services $107.28 General
10/19/2023 Biogen, Inc. Food and Beverage In-kind items and services $111.83 General
08/31/2023 ATRICURE, INC. SYNERGY ABLATION SYSTEM (Device) Food and Beverage In-kind items and services $79.00 General
Category: CARDIOVASCULAR
04/22/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $118.81 General
Category: INSOMNIA
01/19/2023 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $116.43 General
Category: ANTIBIOTIC
10/20/2022 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $122.32 General
Category: Genetic Disease
08/02/2022 Biogen, Inc. Food and Beverage In-kind items and services $87.50 General
05/19/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $101.20 General
Category: KRYSTEXXA
01/20/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $88.53 General
Category: NEUROSCIENCE
10/21/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $113.71 General
Category: Virology & Specialty Care
08/25/2021 KCI USA, Inc. V.A.C. VERAFLO (Device) Food and Beverage Cash or cash equivalent $58.78 General
Category: Negative Pressure Systems & Dressings

About Megan Chipman, ARNP

Megan Chipman, ARNP is a Family healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821546409.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Megan Chipman, ARNP has received a total of $1,153 in payments from pharmaceutical and medical device companies, with $154.58 received in 2024. These payments were reported across 12 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,153).

Practice Information

  • Specialty Family
  • Location Winter Park, FL
  • Active Since 09/13/2016
  • Last Updated 09/13/2016
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1821546409

Products in Payments

  • FABRAZYME (Biological) $122.32
  • QUVIVIQ (Drug) $118.81
  • NUZYRA (Drug) $116.43
  • Xofluza (Drug) $113.71
  • KRYSTEXXA (Biological) $101.20
  • UBRELVY (Drug) $88.53
  • SYNERGY ABLATION SYSTEM (Device) $79.00
  • V.A.C. VERAFLO (Device) $58.78
  • FARXIGA (Drug) $47.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Winter Park